跳至主要内容
临床试验/IRCT2014121920368N1
IRCT2014121920368N1已完成3 期

Effect of lovastatin on response rate and acute side effects of chemoradiation in locally advanced head and neck squamous cell carcinoma: A phase III randomized clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 35 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • inclusion criteria: pathologic evidence of locally advanced(T3,T4,N+) SCC of oral cavity,larynx and hypopharynx; being candidated for definitive chemoradiation; absence of underlying liver or kidney disease; not receiving any drug that interferes with metabolism of lovastatin.
  • Exclusion criteria: initiation of possible lovastatin side effects such as myopathy and liver toxicity; inability to swallow lovastatin tablets

排除标准

  • 未提供

研究者

相似试验